ABSTRACT
As the Covid-19 pandemic soars around the world, there is urgent need to forecast the number of cases worldwide at its peak, the length of the pandemic before receding and implement public health interventions to significantly stop the spread of Covid-19. Widely used statistical and computer methods for modeling and forecasting the trajectory of Covid-19 are epidemiological models. Although these epidemiological models are useful for estimating the dynamics of transmission od epidemics, their prediction accuracies are quite low. To overcome this limitation, we formulated the real-time forecasting and evaluating multiple public health intervention problem into forecasting treatment response problem and developed recurrent neural network (RNN) for modeling the transmission dynamics of the epidemics and Counterfactual-RNN (CRNN) for evaluating and exploring public health intervention strategies to slow down the spread of Covid-19 worldwide. We applied the developed methods to the real data collected from January 22, 2020 to May 8, 2020 for real-time forecasting the confirmed cases of Covid-19 across the world.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Wei Lin is supported by the National Key R&D Program of China (Grant no. 2018YFC0116600), by the National Natural Science Foundation of China (Grant nos. 11925103 & 61773125), and by the STCSM (Grant no. 18DZ1201000).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exemption.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Corrected misprint of the title and updated results.
Data Availability
Data on the number of cumulative and new cases and COVID-19-attributed deaths across 184 countries from January 22, 2020 to April 7 were obtained from John Hopkins Coronavirus Resource Center (https://coronavirus.jhu.edu/MAP.HTML).
